Across
- 2. Fill in the blank: "Tepadina® is a _______ agent that has the peculiar characteristic of crossing the blood-brain barrier, thus exerting its antileukemic activity even in sanctuary sites"
- 3. Fill in the blank: "Transforming HSCT ______ with Tepadina®"
- 4. "Tepadina®-based ASCT (Following MATRix): Enhances 7-year OS to 70%, QoL, and cognition in PCNSL patients." What does the letter "L" in PCNSL stand for?
- 6. True or False: With the use of Tepadina® in haplo-HSCT, it enables reduced ATG and PT-Cy doses, improving 2-year GRFS to 60% (p=0.04).
- 7. Fill in the blank: "Tepadina® is used as a ‘_____’ (preparative) treatment before transplantation of haematopoietic progenitor cells (the cells that make blood cells)"
Down
- 1. Tepadina® is used as a conditioning agent prior to HSCT. What does the letter "T" stand for?
- 5. What is the original brand name of thiotepa?
